---
title: "Healthcare Stocks Decline as Investors Rotate Away from Safety — Healthcare Roundup"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291845146.md"
description: "Healthcare stocks declined as investors rotated away from safety sectors. Invivyd received FDA notice terminating emergency use authorization for its Covid-19 drug Pemgarda by June 29, 2027. Clarivate shares fell after agreeing to sell its life-science and healthcare segment to Altaris for $600 million to focus on AI-driven intelligence."
datetime: "2026-07-06T21:07:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291845146.md)
  - [en](https://longbridge.com/en/news/291845146.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291845146.md)
---

# Healthcare Stocks Decline as Investors Rotate Away from Safety — Healthcare Roundup

Stocks in the healthcare sector fell as investors rotated away from lower-risk industries amid growing tech bullishness.

Invivyd said regulators are ending emergency use authorization for its Covid-19 prevention medication, Pemgarda. The Food and Drug Administration sent Invivyd a notice of termination, with the designation set to end June 29 of next year.

Shares of Clarivate fell after the company said it was selling its life-science and healthcare segment to Altaris, a New York investment firm, for $600 million. Clarivate, a London-based provider of global information, analytics and workflow solutions, said the sale would allow it to focus on AI-driven intelligence for its academic and government and intellectual-property segments.

Write to Paulo Trevisani at paulo.trevisani@wsj.com

(END) Dow Jones Newswires

July 06, 2026 17:00 ET (21:00 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

### Related Stocks

- [CLVT.US](https://longbridge.com/en/quote/CLVT.US.md)
- [IVVD.US](https://longbridge.com/en/quote/IVVD.US.md)

## Related News & Research

- [Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development | CLVT Stock News](https://longbridge.com/en/news/295073955.md)
- [Clarivate forecasts 2026 adjusted diluted EPS at $0.70-$0.80](https://longbridge.com/en/news/294190504.md)
- [The AI bros are lonely](https://longbridge.com/en/news/294942232.md)
- [Don't outsource the best parts of parenting to AI](https://longbridge.com/en/news/294802357.md)
- [White House advisor says companies are blaming AI for layoffs because 'it plays better in the press'](https://longbridge.com/en/news/295080547.md)